BMG Pharma S.r.l., a specialty pharmaceutical company, has announced the European regulatory approval for its GelX product to be used for the prevention of oral mucositis. This new regulatory approval for GelX is the first for a medical product to be used for both the treatment and prevention of oral mucositis in cancer patients. The approval…